26 September 2023 in Russian Journal of Human Reproduction
Endometriosis is a benign gynecologic disease characterized by the presence of endometrial-like tissue outside the uterine cavity. The prevalence of this disease reaches 10—15 per cent among women of reproductive age. There is no single accepted theory of the development of both endometriosis and adenomiosis. This paper presents the genetic aspects of their etiology identified over the last decade. The aim of this literature review is to identify the etiological factors of these diseases for further development of methods of early diagnosis, identification of risk factors of development and recurrence, as well as new methods of treatment based on moleculargenetic features of endometriosis and adenomiosis.
26 September 2023 in Russian Journal of Human Reproduction
Преждевременная недостаточность яичников (ПНЯ) является одной из основных причин женского бесплодия вследствие снижения овариального резерва. ПНЯ затрагивает примерно 1—3,7% женщин. Это состояние характеризуется прекращением менструаций (аменорей или олигоменореей) в течение не менее 4 мес, повышением уровня гонадотропина (уровень фолликулостимулирующего гормона превышает уровень лютеинизирующего гормона) и гипоэстрогенией. К причинам развития данного синдрома особую роль отводят генетическим факторам, например вариантам мутаций в генах ингибина, генах GALT, HFM1, BMP и GDF9, FOXL2, NR5A1. Нарушения структуры и количества половых хромосом представляют собой наиболее распространенную причину ПНЯ (например, синдром Тернера или структурные аномалии X-хромосомы). Целью обзора является анализ современных данных о генетических аспектах ПНЯ для выявления факторов риска, ранней диагностики и своевременной реализации репродуктивной функции пациентов этой когорты.
26 September 2023 in Russian Journal of Human Reproduction
Uterine fibroids are benign monoclonal tumors that occur in approximately 70% of women of reproductive age. Despite many studies, the causes of leiomyomas are still not fully understood. To date, a huge amount of data has been accumulated all over the world on the use of metagenomic, metatranscriptome, and metamethylome methods for the analysis of complete genomes of tumors, including leiomyomas. More than 100 genetic polymorphisms associated with a hereditary predisposition to the occurrence of leiomyomas have been identified. However, despite numerous publications on meta-transcriptomics, meta-methylomics, and GWAS studies in uterine leiomyoma, the results of these studies have hardly been used to develop new therapeutic agents. Further research should be aimed at developing new effective drugs for the prevention, treatment and prevention of recurrence of uterine fibroids. Aim. To improve the efficiency of diagnosis, treatment and identification of risk factors for recurrence by analyzing modern ideas about genetic changes that cause the development of genetically different variants of uterine fibroids, as well as generalizing all approaches to non-surgical methods of treating the disease based on the latest data from metagenomic, metatranscriptome and metamethylome methods for analyzing whole genomes.
26 September 2023 in Russian Journal of Human Reproduction
Mayer—Rokitansky—Küster—Hauser syndrome (MRKH), or Müllerian aplasia, consists of congenital absence of the uterus and vagina. The article presents current data on the role of genetic factors in the malformations of the genital organs. PubMed, Cochrane library, eLibrary databases were searched. As a result of using combinations of keywords: (genetics) AND (MRKH syndrome); 186 articles were identified. 36 papers were selected and their data included in the literature review. As there is a wider adoption of WGS techniques in MRKH studies, it is likely that, in the future, more genes and genetic regions will be identified. Based on this knowledge, the prevention of the syndrome could also be possible through the development of appropriate gene therapy.